Beijing, China

Ming Zeng

This inventor holds 5 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Nuctech Company Limited, Tsinghua University, Chengdu Olymvax Biopharmaceuticals Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Zeng. Retrieved from https://idiyas.com/inventor/ming-zeng-7of7s20e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Guangzhou, CN (2017)
  • Beijing, CN (2020 - 2023)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ming Zeng

Introduction: Ming Zeng, a pioneering inventor hailing from Beijing, CN, has made significant contributions to the world of technology and innovation.

Latest Patents: Ming Zeng's latest patents focus on cutting-edge advancements in artificial intelligence, renewable energy, and sustainable technologies.

Career Highlights: With a career spanning over two decades, Ming Zeng has held key roles in leading tech companies, driving groundbreaking research and development projects, and mentoring the next generation of inventors.

Collaborations: Ming Zeng has collaborated with top research institutions, universities, and multinational corporations to push the boundaries of innovation and bring revolutionary ideas to life.

Conclusion: Ming Zeng's relentless passion for innovation and his commitment to creating a better future through technology make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…